Award
Delivery Order #SPE2DR26FM6AJ
Delivery Order for Quillivant XR Medication under AmerisourceBergen IDV
Buyer
Defense Logistics Agency
Award Amount
$925.48
Ceiling
$925.48
Awarded
March 09, 2026
Period of Performance
Mar 09, 2026 – Mar 10, 2026
Identifier
SPE2DR26FM6AJ
NAICS
424210
This award is a delivery order contract issued to AmerisourceBergen Drug Corporation, a leading pharmaceutical distributor, under a previously established indefinite delivery vehicle (IDV) contract focusing on pharmaceutical supplies. The specific procurement involves the purchase of Quillivant XR 25 MG/5 ML suspension, a medication essential for healthcare treatment regimens. This contract is a short-term, targeted delivery ensuring timely availability of the medication to meet immediate needs. AmerisourceBergen's established role in distributing critical pharmaceutical products underscores the importance of maintaining a reliable supply chain for healthcare providers and public health sectors. The contract execution covers a brief performance period within a multi-year IDV framework, reinforcing ongoing support for pharmaceutical procurement. This delivery order was likely awarded based on the parent IDV's established terms, indicating a streamlined acquisition process rather than a separate competitive bid. The contract performance is set in Conshohocken, Pennsylvania, highlighting a geographical focus for delivery and distribution operations. This award contributes to sustaining drug availability and supports patient care continuity.
Description
4571088088!QUILLIVANT XR 25 MG/5 ML SUSP 180ML